Results 1 to 10 of about 6,064 (187)

Gamma Delta (γδ) T Cells and Their Involvement in Behçet’s Disease [PDF]

open access: yesJournal of Immunology Research, 2015
Behçet’s disease (BD) is a multisystem inflammatory disorder characterized by orogenital ulcerations, ocular manifestations, arthritis, and vasculitis. The disease follows a relapsing-remitting course and its pathogenesis is unknown.
Md. Samiul Hasan   +3 more
doaj   +3 more sources

Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignancies [PDF]

open access: yesHemaSphere
Gamma delta (γδ) T cells, which constitute about 5%–10% of peripheral blood lymphocytes, play key roles in tumor immunosurveillance and are often enriched within epithelial tissues.
Charles Agbuduwe   +2 more
doaj   +3 more sources

Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran [PDF]

open access: yesCells, 2020
Gamma delta (γδ) T cells are a small subset of CD3-positive T cells in the peripheral blood but occur at increased frequency in mucosal tissues [...]
Dieter Kabelitz
doaj   +2 more sources

γδ T cells in 3D culture: The potential use in the therapeutics development

open access: yesClinical and Translational Discovery, 2022
Gamma‐delta (γδ) T cells have a promising future in various therapies due to their anti‐cancer and anti‐infectious function. As the unique T cell subset plays a vital role in the connection between innate and adaptive immunity, we discussed the potential
Shih‐Han Wang   +4 more
doaj   +2 more sources

Potential of gamma/delta T cells for solid tumor immunotherapy

open access: yesFrontiers in Immunology
Gamma/delta T (γδ T)cells possess a unique mechanism for killing tumors, making them highly promising and distinguished among various cell therapies for tumor treatment.
Dantong Zhu   +9 more
doaj   +3 more sources

Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy [PDF]

open access: yesJournal for ImmunoTherapy of Cancer
Genetic engineering has fundamentally transformed T cell–based therapies by enabling tumor targeting capability, improving their functionality, and facilitating allogeneic use. These strategies—originally developed in αβ chimeric antigen receptor (CAR)-T
Wenlong Liu   +2 more
doaj   +2 more sources

Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer

open access: yesNature Communications, 2021
Gamma delta (γδ) T cells have potential for use in immunotherapy against tumours. Here, the authors demonstrate that treatment of tumours with DNA methyltransferase inhibitors modulates cytoskeleton arrangements, upregulates adhesion molecules and ...
Rueyhung R. Weng   +19 more
doaj   +1 more source

γδ T Cell in Cerebral Ischemic Stroke: Characteristic, Immunity-Inflammatory Role, and Therapy

open access: yesFrontiers in Neurology, 2022
Gamma-delta (γδ) T cells are a small subset of T cells that are reported to have a proinflammatory role in the pathophysiology of cerebral ischemia stroke (CIS). Upon activation by interleukin-1 beta (IL-1β), IL-23 and IL-18, γδ T cells are stimulated to
Li Wang   +10 more
doaj   +1 more source

Immune Effects of γδ T Cells in Colorectal Cancer: A Review

open access: yesFrontiers in Immunology, 2020
Gamma delta (γδ) T cells can effectively recognize and kill colorectal cancer (CRC) cells, thereby suppressing tumor progression via multiple mechanisms. They also have abilities to exert a protumor effect via secreting interleukin-17 (IL-17). γδ T cells
Rulan Ma   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy